Drug reference
diiodohydroxyquin
8-Hydroxyquinoline · Luminal antiamoebic, Antiprotozoal, Antifungal, Antibacterial
8-HydroxyquinolineLuminal antiamoebic, Antiprotozoal, Antifungal, Antibacterial
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Kills the cyst forming amoebic trophozoites in the intestine, but does not have tissue amoebicidal action (similar to quiniodochlor).
Indications
Intestinal amoebiasisGiardiasisLocal treatment of monilial vaginitisLocal treatment of trichomonas vaginitisLocal treatment of fungal skin infectionsLocal treatment of bacterial skin infections
Dosing
- Adult
- 650 mg TDS (not to exceed 2.0 g/day for 14 days).
- Geriatric
- 200 mg inserted intravaginally at bedtime for 1–2 weeks (for trichomoniasis).
Side effects
Serious
- neuropathy
- visual impairment
Related guidelines
Other 8-Hydroxyquinoline drugs
Ask House about diiodohydroxyquin
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team